Rights and permissions
About this article
Cite this article
Metastatic and PSA progression inflate costs in prostate cancer. Pharmacoecon. Outcomes News 456, 10 (2004). https://doi.org/10.2165/00151234-200404560-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404560-00026